Lindsay Mitchell

Lindsay Christopher Mitchell (born 28 May 1949) is an English-born Canadian musician and songwriter who achieved success as the guitarist and founder of the Canadian rock band Prism. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Lindsay Mitchell', query time: 0.03s Refine Results
  1. 1
    The influence of a virtual reality entertainment program on depressive symptoms and sedentary behaviour in inpatient stroke survivors: a research protocol for a pilot randomized controlled trial

    The influence of a virtual reality entertainment program on depressive symptoms and sedentary behaviour in inpatient stroke survivors: a research protocol for a pilot randomized co... by Isabelle Rash, Megan Helgason, Donna Jansons, Lindsay Mitchell, Brodie M. Sakakibara

    Published 2022-10-01
    Get full text
    Article
  2. 2
    When high viscosity of pancreatic cysts precludes effective EUS-FNA: a benchtop comparison of negative pressure devices

    When high viscosity of pancreatic cysts precludes effective EUS-FNA: a benchtop comparison of negative pressure devices by Leonard T. Walsh, Lindsay Mitchell, Ansh Johri, Nicholas Matone, Mary Frecker, Matthew Moyer

    Published 2019-04-01
    Get full text
    Article
  3. 3
    One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study

    One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study by Hubert Schrezenmeier, Austin Kulasekararaj, Lindsay Mitchell, Flore Sicre de Fontbrune, Timothy Devos, Shinichiro Okamoto, Richard Wells, Scott T. Rottinghaus, Peng Liu, Stephan Ortiz, Jong Wook Lee, Gérard Socié

    Published 2020-10-01
    Get full text
    Article
  4. 4
    Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria.

    Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. by John Devin Peipert, Austin G Kulasekararaj, Anna Gaya, Saskia M C Langemeijer, Susan Yount, F Ataulfo Gonzalez-Fernandez, Emilio Ojeda Gutierrez, Christa Martens, Amy Sparling, Kimberly A Webster, David Cella, Ioannis Tomazos, Masayo Ogawa, Caroline I Piatek, Richard Wells, Flore Sicre de Fontbrune, Alexander Röth, Lindsay Mitchell, Anita Hill, Karen Kaiser

    Published 2020-01-01
    Get full text
    Article

Search Tools: